3 days Ago By ABMN Staff
Thermo Fisher Scientific Inc. ( NYSE:TMO – Free Report ) – Investment analysts at Leerink Partnrs decreased their Q3 2025 earnings estimates for Thermo Fisher Scientific in a research note issued to investors on Friday, September 13th. Leerink Partnrs analyst P.
Souda now forecasts that the medical research company will earn $5.91 per share for the quarter, down from their previous forecast of $6.00.
The consensus estimate for Thermo Fisher Scientific’s current full-year earnings is $21.72 per share. Thermo Fisher Scientific ( NYSE:TMO – Get Free Report ) last announced its quarterly earnings data on Wednesday, July 24th.
The medical research company reported $5.37 earnings per share for the quarter, beating analysts’ consensus estimates of $5.13 by $0.
24. Thermo Fisher Scientific had a return on equity of 18.22% and a net margin of 14.
69%. The company had revenue of $10.54 billion for the quarter, compared to analyst estimates of $10.
50 billion. During the same quarter in the previous year, the company earned $5.15 EPS.
The firm’s revenue for the quarter was down 1.4% compared to the same quarter last year. Read Our Latest Report on Thermo Fisher Scientific Thermo Fisher Scientific Trading Down 0.
5 % Shares of TMO opened at $611.17 on Monday. The firm’s 50-day moving average is $592.
10 and its two-hundred day moving average is $580.22. Thermo Fisher Scientific has a twelve month low of $415.
60 and a twelve month high of $627.88. The company has a current ratio of 1.
72, a quick ratio of 1.37 and a debt-to-equity ratio of 0.64.
The firm has a market capitalization of $233.47 billion, a P/E ratio of 39.20, a PEG ratio of 2.
86 and a beta of 0.78. Thermo Fisher Scientific Announces Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th.
Stockholders of record on Friday, September 13th will be given a $0.39 dividend. This represents a $1.
56 annualized dividend and a dividend yield of 0.26%. The ex-dividend date is Friday, September 13th.
Thermo Fisher Scientific’s payout ratio is currently 10.01%. Insider Activity at Thermo Fisher Scientific In related news, CEO Marc N.
Casper sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $617.21, for a total transaction of $6,172,100.
00. Following the transaction, the chief executive officer now directly owns 123,816 shares of the company’s stock, valued at approximately $76,420,473.36.
The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink . In other news, CEO Marc N. Casper sold 10,000 shares of Thermo Fisher Scientific stock in a transaction dated Wednesday, July 31st.
The stock was sold at an average price of $617.21, for a total transaction of $6,172,100.00.
Following the sale, the chief executive officer now directly owns 123,816 shares of the company’s stock, valued at $76,420,473.36. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink .
Also, EVP Gianluca Pettiti sold 300 shares of Thermo Fisher Scientific stock in a transaction that occurred on Friday, July 26th. The stock was sold at an average price of $600.85, for a total value of $180,255.
00. Following the sale, the executive vice president now owns 17,887 shares in the company, valued at $10,747,403.95.
The disclosure for this sale can be found here . In the last 90 days, insiders have sold 23,084 shares of company stock worth $14,094,292. 0.
34% of the stock is currently owned by corporate insiders. Hedge Funds Weigh In On Thermo Fisher Scientific Several large investors have recently added to or reduced their stakes in the company. Accretive Wealth Partners LLC lifted its stake in Thermo Fisher Scientific by 8.
1% during the fourth quarter. Accretive Wealth Partners LLC now owns 640 shares of the medical research company’s stock valued at $340,000 after buying an additional 48 shares in the last quarter. Aveo Capital Partners LLC raised its position in Thermo Fisher Scientific by 9.
7% during the fourth quarter. Aveo Capital Partners LLC now owns 816 shares of the medical research company’s stock valued at $433,000 after buying an additional 72 shares during the period. Gryphon Financial Partners LLC lifted its stake in Thermo Fisher Scientific by 8.
5% in the 4th quarter. Gryphon Financial Partners LLC now owns 1,484 shares of the medical research company’s stock worth $794,000 after acquiring an additional 116 shares in the last quarter. AMG National Trust Bank grew its stake in Thermo Fisher Scientific by 10.
0% during the 4th quarter. AMG National Trust Bank now owns 2,569 shares of the medical research company’s stock valued at $1,363,000 after acquiring an additional 234 shares in the last quarter. Finally, TrinityPoint Wealth LLC increased its holdings in shares of Thermo Fisher Scientific by 4.
2% in the 4th quarter. TrinityPoint Wealth LLC now owns 4,080 shares of the medical research company’s stock valued at $2,166,000 after purchasing an additional 164 shares during the period. 89.
23% of the stock is currently owned by institutional investors. About Thermo Fisher Scientific ( Get Free Report ) Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Recommended Stories Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter ..
